Skip to main content
. 2021 Sep 9;10(9):1162. doi: 10.3390/pathogens10091162

Table 2.

Antimicrobial susceptibility profiles of different bacterial hosts carrying blaCTX-M and blaTEM-positive plasmids, E. coli-J53 transconjugants and the E. coli-J53 recipient.

Strains 1 MICs (μg/mL) 2
TET TES AMC CEP AZT MPN AMP CTX KAN CIP
1557 128 8/160 128/64 16 >64 0.15 >256 >256 1024 64
T-1557 1 1/10 128/64 8 16 0.15 >256 >256 0.25 0.25
1584 512 8/320 128/64 16 32 0.15 >256 >256 64 128
T-1584 1 1/10 128/64 8 8 0.15 >256 >256 0.25 0.25
1587 256 8/160 128/64 16 >64 0.15 >256 >256 256 128
T-1587 1 1/10 128/64 8 16 0.15 >256 >256 0.25 0.25
1591 256 8/320 64/32 16 >64 0.15 >256 >256 256 64
T-1591 1 1/10 64/32 8 16 0.15 >256 >256 0.25 0.25
J53 1 1/10 1/0.5 0.25 1 0.03 2 0.25 0.25 0.25

1 T-1557, T-1584, T-1587 and T-1591 represent the transconjugations of E. coli 1557, E. coli 1584, E. coli 1587 and E. coli 1591. 2 MIC, minimum inhibitory concentration. Antimicrobial agents are abbreviated as follows: Tetracycline (TET), Trimethoprim-sulfamethoxazole (TES), Amoxicillin-clavulanate (AMC), Cefepime (CEP), Aztreonam (AZT), Meropenem (MPN), Ampicillin (AMP), Cefotaxime (CTX), Kanamycin (KAN), Ciprofloxacin (CIP). Data are summarised from three different experiments.